Outlook Therapeutics, Inc. (OTLK) Free cash flow 2016–2019
Outlook Therapeutics, Inc. (OTLK) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$32.7MFY2019 · since FY2016: -$46.6M → -$32.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2019 | -$32.7M | +8.6% |
| FY2018 | -$35.8M | -126.8% |
| FY2017 | -$15.8M | +66.1% |
| FY2016 | -$46.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice